Pages that link to "Q41365394"
Jump to navigation
Jump to search
The following pages link to Increased hydroxyl radical production in liver peroxisomal fractions from rats treated with peroxisome proliferators (Q41365394):
Displaying 24 items.
- Oxaliplatin neurotoxicity involves peroxisome alterations. PPARγ agonism as preventive pharmacological approach (Q33921641) (← links)
- Biochemistry of peroxisomes in health and disease (Q34418889) (← links)
- Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk (Q34734778) (← links)
- An overview of peroxisome proliferator-induced hepatocarcinogenesis (Q35034202) (← links)
- PPARalpha agonist-induced rodent tumors: modes of action and human relevance (Q35631058) (← links)
- Role of oxidative stress in peroxisome proliferator-mediated carcinogenesis (Q36059868) (← links)
- Literature review of the role of hydroxyl radicals in chemically-induced mutagenicity and carcinogenicity for the risk assessment of a disinfection system utilizing photolysis of hydrogen peroxide (Q36082405) (← links)
- Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver. (Q36586072) (← links)
- PPAR- γ impairment alters peroxisome functionality in primary astrocyte cell cultures (Q37650379) (← links)
- The relevance of peroxisome proliferation and cell proliferation in peroxisome proliferator-induced hepatocarcinogenesis (Q38769611) (← links)
- Possible mechanisms in hepatocarcinogenesis by the peroxisome proliferator di(2-ethylhexyl)phthalate (Q38769640) (← links)
- Spin trapping: ESR parameters of spin adducts (Q39163653) (← links)
- Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis (Q40863132) (← links)
- Effects of the peroxisome proliferator clofibric acid on superoxide dismutase expression in the human HepG2 hepatoma cell line (Q40925188) (← links)
- Effect of hypoxia-reoxygenation on peroxisomal functions in cultured human skin fibroblasts from control and Zellweger syndrome patients (Q41389708) (← links)
- Protein refolding in peroxisomes is dependent upon an HSF1-regulated function. (Q42509266) (← links)
- Inhibition of PPAR alpha/RXR alpha-mediated direct hyperplasia pathways during griseofulvin-induced hepatocarcinogenesis (Q42543354) (← links)
- Significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats following short-term exposure to the peroxisome proliferators di(2-ethylhexyl)phthalate and di(2-ethylhexyl)adipate. (Q53509409) (← links)
- Peroxisomal oxidases and catalase in liver and kidney homogenates of normal and di(ethylhexyl)phthalate-fed rats (Q67827473) (← links)
- Peroxisome proliferation due to di (2-ethylhexyl) adipate, 2-ethylhexanol and 2-ethylhexanoic acid (Q68164253) (← links)
- Induction of hepatic microsomal CYP4A activity and of peroxisomal beta-oxidation by two non-steroidal anti-inflammatory drugs (Q72412004) (← links)
- Studies on hepatic injury and antioxidant enzyme activities in rat subcellular organelles following in vivo ischemia and reperfusion (Q73957916) (← links)
- Effect of the peroxisome proliferator ciprofibrate on lipid peroxidation and 8-hydroxydeoxyguanosine formation in transgenic mice with elevated hepatic catalase activity (Q74704831) (← links)
- Manganese superoxide dismutase in rat liver peroxisomes: biochemical and immunochemical evidence (Q78256757) (← links)